suzanne-hodsden-articles
-
Implantable Cardiac Monitor Could Last Seven Decades In The Body
3/3/2017
Northwestern scientists have developed a paper-thin patch that could adhere to the surface of the heart and monitor its activity. The researchers claim that innovations with the materials used in the patch could allow the implant to last up to seventy years without leaking.
-
Nanostraws Collect Samples From Cells Without Causing Damage
3/2/2017
Originally designed to deliver molecules into cells, researchers have demonstrated that “nanostraws” can extract molecules and genetic material from inside the cells —an advance that could lead to better understanding of cell development, chemotherapy resistance, and the discovery of more effective therapies.
-
Velano Vascular Snags Third FDA Clearance For Needle-Free Blood Draw Device
3/1/2017
Velano Vascular announced that the company has secured a third FDA 510(k) clearance for its next-generation design of PIVO, a device that can collect blood samples through peripheral intravenous (IV) lines, preventing additional and unnecessary needle sticks for hospitalized patients.
-
Portable ECG Device Delivers Actionable Data In Under One Minute
2/27/2017
A novel electrocardiograph (ECG) device uses metal sensors in contact with the user’s hands or feet to collect actionable data in under a minute. The device’s Spanish developers claim that the affordable and easy-to-use technology could facilitate earlier diagnosis of cardiac events, even in remote locations with low medical resources, or the patient’s home.
-
Stanford's “Artificial Synapse” May Lead To Improvements In Brain-Machine Interfaces
2/24/2017
New technology from Stanford University is moving beyond devices that simulate a neural network, attempting rather to recreate a neural network with a biocompatible artificial synapse, the part of a neural network that allows neurons to pass chemical signals to another neuron.
-
Medtronic CEO Reports “Solid” Revenue Rebound, Remains Mum On Medical Supplies Business Sale
2/23/2017
Medtronic beat estimates this week with “solid” performance in all of its businesses and markets, said CEO Omar Ishrak, which puts the company back on track after reported Q2 slowdown last year.
-
Philips Launches Healthcare Informatics Service, Gets FDA Nod For Patient-Monitoring Device
2/22/2017
Philips aims to meet the needs of growing economic uncertainty and rapidly advancing digital health market with a high-performance, scalable health informatics platform featuring an end-to-end managed service and risk-sharing pay-per-use model, according to senior executives.
-
Long-Lasting Injectable CGM Uses Live Cells To Regenerate Sensor
2/21/2017
The Juvenile Diabetes Research Fund (JDRF) has invested in a long-lasting continuous glucose monitor (CGM) that uses engineered live cells to replenish and maintain the stability of the implant’s optical biosensor over time.
-
FDA Clears Portable Device To Improve Blood Flow At Home Or In Clinical Settings
2/17/2017
FlowAid Medical Technologies (FlowAid), makers of non-invasive devices and therapies for circulatory disorders affecting extremities, have announced FDA approval for a calf muscle stimulation system that reduces incidence of blood clots and swelling.
-
Integra LifeSciences To Buy J&J's Neurosurgery Business For $1.05 Billion
2/16/2017
Integra LifeSciences has agreed to purchase Johnson & Johnson (J&J) subsidiary Codman Neurosurgery for $1.05 billion, with plans to build a more comprehensive neurosurgery portfolio and expand its international foothold.